All Resources

AAO24: Allergic Rhinitis: Avoidance of Leukotriene Inhibitors

AAO24: Allergic Rhinitis: Avoidance of Leukotriene Inhibitors

Download PDF

High Priority: Yes; Appropriate Use
Percentage of patients age 2 years and older patients with allergic rhinitis who do not receive leukotriene inhibitors.

Denominator:
All patients age 2 years and older with allergic rhinitis with a diagnosis of allergic rhinitis who do not have an active order
(prescription or reported over the counter use) of intranasal corticosteroids or second generation antihistamines.

Denominator Exclusions:
Exclude patients with concomitant diagnosis of asthma or sleep apnea.

Denominator Exceptions:
Patients with allergy to intranasal corticosteroids, allergy to second generation antihistamines, or prostate issues (due to
concern for intolerance of primary therapy options).

Numerator:
Patients who do not receive leukotriene inhibitors.

Measure Classifications:

  • Measure Type: Process
  • National Quality Strategy (NQS) domain: Effective Clinical Care
  • Meaningful Measure Area: Medication Management
  • Calculation: 1st Performance Rate
    • Inverse measure: No
    • Continuous measure: No
    • Proportional measure: Yes
    • Ratio measure: No
    • Risk Adjusted measure: No
AAO-HNS COVID-19 InformationLearn More